ADXN logoADXN
Addex Therapeutics Ltd - ADR

2,620
Loading...
Loading...
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2

Frequently Asked Questions

What is Market Cap of Addex Therapeutics Ltd - ADR?
What is the 52-week high for Addex Therapeutics Ltd - ADR?
What is the 52-week low for Addex Therapeutics Ltd - ADR?
What is Addex Therapeutics Ltd - ADR stock price today?
What was Addex Therapeutics Ltd - ADR stock price yesterday?
What is the PE ratio of Addex Therapeutics Ltd - ADR?
What is the Price-to-Book ratio of Addex Therapeutics Ltd - ADR?
What is the 50-day moving average of Addex Therapeutics Ltd - ADR?
How many employess does Addex Therapeutics Ltd - ADR has?

Latest ADXN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.